FDA Inspection 794869 — McGuff Pharmaceuticals, Inc.

McGuff Pharmaceuticals, Inc. — FEI 2022073

The FDA completed an inspection of McGuff Pharmaceuticals, Inc. on August 16, 2012 in Santa Ana, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 16, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Santa Ana, CA (United States)